Loading clinical trials...

Genotype-Phenotype Correlations in Patients With Alport Syndrome | Clinical Trials | Clareo Health

RECRUITINGNCT04947813

Genotype-Phenotype Correlations in Patients With Alport Syndrome

Alport syndrome (AS) is caused by pathogenic variants in the type IV collagen genes COL4A3, COL4A4, and COL4A5. This study aims to enroll families and patients with a history of renal hematuria in 27 ...

Lead sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 4

Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients with Alport Syndrome (COMBINE-ALPORT)

NCT06499948 · Alport Syndrome, Thin Basement Membrane Disease, and more

RECRUITING

National Registry of Rare Kidney Diseases

NCT06065852 · Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, and more

Active Not Recruiting

Effects of Dapagliflozin on Progression of Alport Syndrome

NCT06226896 · Alport Syndrome

Not Yet Recruiting

Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)

NCT07575347 · Periodontal Disease, Periodontitis, and more

COMPLETED

Alport Syndrome Treatments and Outcomes Registry

NCT00481130 · Alport Syndrome

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 1, 2021Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment8,165

Start dateJan 2021

Last updatedJul 1, 2021

Condition

Alport Syndrome

Locations shown

China Xinhua Hospital, Shanghai Jiao Tong University School of Medicine.

Shanghai

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 1, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions